Dodecylmaltoside-mediated nasal and ocular absorption of lyspro insulin: Independence of surfactant action from multimer dissociation

Pharmaceutical Research

Volumn 15, Issue 10, 1998, Pages 1637-1639

  Pillion, Dennis J ^a   Hosmer, Susan ^a   Meezan, Elias ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Diabetes mellitus; Drug delivery; Excipient; Eye; Insulin; Nose

Indexed keywords

DODECYLMALTOSIDE; EXCIPIENT; EYE DROPS; GLYCOSIDE; INSULIN LISPRO; ISOPHANE INSULIN; NOSE DROPS; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DIABETES MELLITUS; DOSE RESPONSE; DRUG ABSORPTION; DRUG FORMULATION; DRUG MECHANISM; INTRANASAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TOPICAL DRUG ADMINISTRATION;

ABSORPTION; ANIMALS; EYE; GLUCOSIDES; INSULIN; MALE; NASAL MUCOSA; RATS; RATS, SPRAGUE-DAWLEY; SURFACE-ACTIVE AGENTS;

EID: 0031718441     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011975721569     Document Type: Article

References (13)

1. S. Hirai, T. Ikenaga, and T. Matsuzawa. Nasal absorption of insulin in dogs, Diabetes. 27:296-299 (1978).
2. G. C. Y. Chiou, C. Chuang, and M. S. Chang. Reduction of blood glucose concentration with insulin eyedrops, Diabetes Care. 11:750-751 (1988).
3. D. J. Pillion, J. D. Bartlett, E. Meezan, M. Yang, R. J. Grain, and W. E. Grizzle. Systemic absorption of insulin delivered topically to the rat eye, Invest. Ophthalmol. Vis. Sci. 32:3021-3027 (1991).
4. D. J. Pillion, J. A. Atchison, J. Stott, D. L. McCracken, C. Garguilo, and E. Meezan. Efficacy of insulin eyedrops, J. Ocul. Pharmacol. 10:461-470 (1994).
5. A. C. Moses, G. S. Gordon, M. C. Carey, and J. S. Flier. Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects, Diabetes. 32:1040-1047 (1983).
6. J. Hilsted, S. Madsbad, A. Hvidberg, et al. Intranasal insulin therapy: the clinical realities, Diabetologia. 38:680-684 (1995).
7. K. Dreyer, A. Vaag, K. Bech, P. Hansen, A. R. Sorensen, and N. Mygind. Intranasal administration of insulin with phospholipid as absorption enhancer: Pharmacokinetics in normal subjects, Diab. Med. 9:335-340 (1992).
8. B. J. Aungst, A. J. Rogers, and E. Shefter. Comparison of nasal, rectal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter, J. Pharmacol. Exp. Therap. 244:23-27 (1988).
9. D. J. Pillion, J. A. Atchison, C. Garguilo, J. Stott, P. Wang, and E. Meezan. Insulin delivery in nosedrops: New formulations containing alkylglycosides, Endocrinology. 135:1386-1391 (1994).
10. D. J. Pillion, P. Wang, J. Yorks, P. McCann, and E. Meezan. Systemic absorption of insulin and glucagon applied to the eyes of rats and a diabetic dog, J. Ocul. Pharmacol. Tox. 11:283-295 (1995).
11. D. J. Pillion, J. A. Atchison, and E. Meezan. Alkylglycosides enhance systemic absorption of insulin applied topically to the rat eye, J. Pharmacol. Exp. Therap. 271:1274-1280 (1994).
12. D. J. Pillion, D. L. McCracken, M. Yang, and J. A. Atchison. Glucagon administration to the rat via eyedrops, J. Ocul. Pharmacol. 8:349-358 (1992).
13. D. C. Howey, R. R. Bowsher, R. L. Brunelle, and J. R. Woodworth. [Lys(B28),Pro(B29)] -human insulin: a rapidly absorbed analog of human insulin, Diabetes. 43:396-402 (1994).